Candel Therapeutics schedules call on prostate cancer trial data
Tweet Send to a Friend
Candel Therapeutics Inc. (NASDAQ: CADL) will host an investor conference call on May 15, 2026, at 1:00 PM ET to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


